Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity

Lu Wang1, Dengqiu Xu1, Liping Li1

  • 1Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.

Toxicology Letters
|September 3, 2018
PubMed

Insights

Triptolide (TP) alters hepatic macrophage function, impairing endotoxin clearance and increasing liver sensitivity to LPS, leading to hepatotoxicity. This study reveals TP

Area of Science:

  • Hepatology
  • Immunology
  • Toxicology

Background:

  • Hepatic macrophages are crucial in liver disease pathogenesis.
  • The impact of triptolide (TP) on hepatic macrophages remains understudied.
  • Understanding TP's effects on these cells is vital for liver health.

Purpose of the Study:

  • To investigate the role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity.
  • To elucidate the mechanism of TP-induced liver injury mediated by macrophages.

Main Methods:

  • Administration of triptolide (TP) and low-dose lipopolysaccharides (LPS) to mice.
  • Analysis of hepatic macrophage numbers, function (phagocytosis), and recruitment.
  • Assessment of liver injury and endotoxin levels.

Main Results:

  • TP treatment increased hepatic macrophage numbers but inhibited their phagocytic function.
  • TP induced monocyte-derived macrophage (MoMF) recruitment, causing inflammation and heightened endotoxin sensitivity.
  • Concurrent TP and LPS administration led to significant hepatotoxicity, unlike LPS alone.

Conclusions:

  • Triptolide impairs the liver's ability to clear endotoxins by altering hepatic macrophage dynamics.
  • TP increases liver sensitivity to low-dose LPS, contributing to hepatotoxicity.
  • Hepatic macrophages play a critical role in the mechanism of TP-induced liver injury.

Related Concept Videos

Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
310
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
247
Role of Septins01:02

Role of Septins

Septins are the recently discovered fourth major protein component of the cytoskeleton, along with microfilaments, microtubules, and intermediate filaments. These proteins can associate with other cytoskeletal filaments and carry out varied roles or can be free-floating in the cytoplasm.
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
2.2K